Hematopoietic Neoplasm clinical trials at UCSF

1 research study open to eligible people

Hematopoietic neoplasms involve abnormal growth of cells in blood-forming tissues. At UCSF, a study is ongoing to see if wearable trackers can predict hospital visits by gathering patient health data. This approach might provide new insights for managing these conditions more effectively.

Showing trials for

  • Wearable Activity Tracking to Curb Hospitalizations

    open to eligible people ages 18 years and up

    This study is being done to collect patient generated health data to predict the risk of patients needing emergency department visits or hospitalization before, during. and after receiving radiation therapy.

    San Francisco, California

Our lead scientists for Hematopoietic Neoplasm research studies include .

Last updated: